Loïc Belle1, Guillaume Cayla2, Yves Cottin3, Pierre Coste4, Khalife Khalife5, Jean-Noël Labèque6, Bruno Farah7, Thibaut Perret8, Patrick Goldstein9, Pierre-Yves Gueugniaud10, François Braun11, Jacques Gauthier12, Martine Gilard13, Jean-Yves Le Heuzey13, Nicolas Naccache13, Elodie Drouet14, Vincent Bataille15, Jean Ferrières15, Etienne Puymirat16, François Schiele17, Tabassome Simon18, Nicolas Danchin19. 1. Department of cardiology, centre hospitalier Annecy-Genevois, Annecy, France, Collège national des cardiologues des hôpitaux, Paris, France. 2. Department of Cardiology, centre hospitalier universitaire de Nîmes, université de Montpellier, Montpellier, France. 3. Department of Cardiology, centre hospitalier universitaire de Dijon, Dijon, France. 4. Department of Cardiology, centre hospitalier universitaire de Bordeaux-Pessac, Bordeaux-Pessac, France. 5. Department of Cardiology, centre hospitalier régional de Metz, Metz, France. 6. Department of Cardiology, centre hospitalier de la Côte-Basque, Bayonne, France. 7. Department of Cardiology, clinique Pasteur, Toulouse, France. 8. Department of Cardiology, centre hospitalier St-Joseph-et-St-Luc, Lyon, France. 9. Emergency Department and SAMU, centre hospitalier régional universitaire de Lille, Lille, France. 10. Société française de médecine d'urgence, Paris, France. 11. SAMU urgences de France, Paris, France. 12. Collège national des cardiologues français, Paris, France. 13. Société française de cardiologie, Paris, France. 14. URC-EST, hôpital St-Antoine, AP-HP, Paris, France. 15. Department of Cardiology and Inserm 1027, Toulouse Rangueil University Hospital, Toulouse, France. 16. Department of Cardiology, hôpital européen Georges-Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris, France; Université Paris-Descartes, Paris, France. 17. Department of Cardiology, centre hospitalier universitaire Jean-Minjoz, Besançon, France. 18. Department of Pharmacology, hôpital St-Antoine, AP-HP, Paris, France; Université Pierre-et-Marie-Curie, Paris 6, France. 19. Department of Cardiology, hôpital européen Georges-Pompidou, AP-HP, 20, rue Leblanc, 75015 Paris, France; Université Paris-Descartes, Paris, France. Electronic address: nicolasdanchin@yahoo.fr.
Abstract
BACKGROUND: The FAST-MI programme, consisting of 1-month surveys of patients admitted to hospital for acute myocardial infarction (AMI) in France, has run since 2005. AIM: To gather data on the characteristics, management and outcomes of patients hospitalized for AMI at the end of 2015 in France and to provide comparisons with the previous surveys. METHODS: Consecutive adults with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment-elevation myocardial infarction (NSTEMI) with symptom onset≤48hours were included over a 1-month period, with a possible extension of recruitment for 1 additional month. Patients with AMI following cardiovascular procedures were excluded. In all, 204 centres participated in the survey (114 community hospitals, 40 academic, 48 private clinics, 2 army hospitals), representing 78% of French centres managing AMI patients. Inclusion started from 5 October 2015. Data were collected on-site from source files by external research technicians, using an electronic case record form with automatic quality checks. Centralized biology was organized in voluntary centres to collect RNA and DNA samples, serum and stools. Long-term follow-up was organized centrally with interrogation of municipal registry offices, physicians and by direct contact with the patients or their families. RESULTS: A total of 5291 patients were included over the entire recruitment period, with 3813 included during the first month (STEMI: 49%, NSTEMI: 51%). Mean age was 66±14 years, 29% were≥75 years of age, 28% were women; 80% presented with typical chest pain. In STEMI patients, 6% received intravenous fibrinolysis and 71% underwent primary PCI. The hospital death rate was 2.7% (STEMI: 2.8%, NSTEMI: 2.5%). CONCLUSIONS: Recruitment was in line with expectations and the first data show that management has continued to evolve since the 2010 survey, with continued improvement in hospital outcomes.
BACKGROUND: The FAST-MI programme, consisting of 1-month surveys of patients admitted to hospital for acute myocardial infarction (AMI) in France, has run since 2005. AIM: To gather data on the characteristics, management and outcomes of patients hospitalized for AMI at the end of 2015 in France and to provide comparisons with the previous surveys. METHODS: Consecutive adults with ST-segment elevation myocardial infarction (STEMI) or non-ST-segment-elevation myocardial infarction (NSTEMI) with symptom onset≤48hours were included over a 1-month period, with a possible extension of recruitment for 1 additional month. Patients with AMI following cardiovascular procedures were excluded. In all, 204 centres participated in the survey (114 community hospitals, 40 academic, 48 private clinics, 2 army hospitals), representing 78% of French centres managing AMI patients. Inclusion started from 5 October 2015. Data were collected on-site from source files by external research technicians, using an electronic case record form with automatic quality checks. Centralized biology was organized in voluntary centres to collect RNA and DNA samples, serum and stools. Long-term follow-up was organized centrally with interrogation of municipal registry offices, physicians and by direct contact with the patients or their families. RESULTS: A total of 5291 patients were included over the entire recruitment period, with 3813 included during the first month (STEMI: 49%, NSTEMI: 51%). Mean age was 66±14 years, 29% were≥75 years of age, 28% were women; 80% presented with typical chest pain. In STEMI patients, 6% received intravenous fibrinolysis and 71% underwent primary PCI. The hospital death rate was 2.7% (STEMI: 2.8%, NSTEMI: 2.5%). CONCLUSIONS: Recruitment was in line with expectations and the first data show that management has continued to evolve since the 2010 survey, with continued improvement in hospital outcomes.
Authors: Chiara Casarin; Anne-Sophie Pirot; Charles Gregoire; Laurence Van Der Haert; Patrick Vanden Berghe; Diego Castanares-Zapatero; Melanie Dechamps Journal: BMC Emerg Med Date: 2022-07-04
Authors: Damien Legallois; Amir Hodzic; Joachim Alexandre; Charles Dolladille; Eric Saloux; Alain Manrique; Vincent Roule; Fabien Labombarda; Paul Milliez; Farzin Beygui Journal: Heart Fail Rev Date: 2022-01 Impact factor: 4.214
Authors: Khalid F Alhabib; Abdulhalim J Kinsara; Saleh Alghamdi; Mushabab Al-Murayeh; Gamal Abdin Hussein; Shukri AlSaif; Hassan Khalaf; Hussam Alfaleh; Ahmad Hersi; Tarek Kashour; Ayman Al-Saleh; Mohammad Ali; Anhar Ullah; Hassan Mhish; Abdulrahman Nouri Abdo; Fawaz Almutairi; Mohammed R Arafah; Raed AlKutshan; Mubarak Aldosari; Basel Y AlSabatien; Mohammad Alrazzaz; Adel M Maria; Aziza H Aref; Muhammed M Selim; Ayman M Morsy; Fathi A AlTohari; Ammar A Alrifai; Awatif A Awaad; Hassan El-Sayed; Sherief Mansour; Ashraf A Atwa; Salah Abdelkader; Naif Altamimi; Elnatheer Saleh; Wael Alhaidari; El Husseini A ElShihawy; Ali H Busaleh; Mohammed Abdalmoutaleb; Essam M Fawzy; Zaki Mokhtar; Adil M Saleh; Mohammed A Ahmad; Adel Almasswary; Mohammed Alshehri; Khalid M Abohatab; Turki AlGarni; Modaser Butt; Ibrahim Altaj; Farhan Abdullah; Yahya Alhosni; Hadia B Osman; Najeebullah Bugti; Atif A Aziz; Abdulrahman Alarabi; Ibrahim A AlHarbi Journal: PLoS One Date: 2019-05-21 Impact factor: 3.240
Authors: Khalid F Alhabib; Habib Gamra; Wael Almahmeed; Ayman Hammoudeh; Salim Benkheddah; Mohammad Al Jarallah; Ahmed Al-Motarreb; Mothanna Alquraishi; Mohamed Sobhy; Magdi G Yousif; Fahad Alkindi; Nadia Fellat; Mohammad I Amin; Muhammad Ali; Ayman Al Saleh; Anhar Ullah; Faiez Zannad Journal: PLoS One Date: 2020-07-22 Impact factor: 3.240